Logo Made in Germany
presented by Logo BMWi
in cooperation with Logo AUMA
Key-Visual BIO 2018

BIO 2018

04 – 07 June 2018

Meet 54 German companies

Welcome to the German Pavilion at BIO 2018!

Biotechnology Exhibition

June 4 -7, 2018
Boston Convention Center
Boston USA

Welcome to the German Pavilion at BIO 2018!

Germany is one of Europe`s most important players in the field of biotechnology.
• Germany is home to about 590 dedicated biotech companies and 130 non-dedicated companies that are also active in the field of biotechnology. Altogether 38 000 employees work in this sector.
• The sales volume of the dedicated companies alone is worth almost EUR 3,4 billion. R&D investment was around 1.05 Mio. Euro in 2015.
• Germany ranks third in worldwide patent applications in biotechnology. One fifth of all biotech patents registered in the EU region are from Germany.
• The majority of German Biotech companies are dedicated to the development of drugs or new methods in diagnostics.
• Germany is the largest producer of biopharmaceuticals within the EU and ranks second worldwide behind the US. In 2015, the turn-over with biopharmaceuticals was 8,2 billion Euro which accounts for 23 percent of the whole German pharmaceutical market.
• Germany is one of the world`s leading industrial biotechnology nations.
• In more than 200 research facilities in Germany, scientists are busy pursuing biotechnological questions and issues. These include 61 universities, 39 technical colleges, 105 non-academic research facilities and 9 sites of state department research.
• Several science and innovation clusters have been established as centers for expertise. The largest of them are settled around Munich, Berlin and North-Rhine Westfalia.
At BIO 2018 in Boston more than 54 German companies and institutions will present themselves with their ambitious product developments and services in the 21st German official presentation at BIO annual convention. These companies and institutions are convinced that their products and ideas will be received with great interest.
The German Federal Ministry for Economic Affairs and Energy (BMWi), the AUMA_Association of the German Trade Industry, German Association of Biotechnology Industries of the German Chemical Industry Association (DIB) and the German Biotechnology-Industry-Organization BIO Deutschland welcome you to the official German Presentation at BIO 2018 in Boston.

Exhibitors at the German Pavilion


ChemCon GmbH
Contract API Manufacturing
Booth number: 1501-7

IIS Innovative Injektions-Systems GmbH & Co. KG
Micro Array Patch
Booth number: 1601-4

Investment and Marketing Corporation Saxony-Anhalt
Biotech Start-up Center Gatersleben
Booth number: 1601-10

Genekam Biotechnology AG
Fluhunter Influenza
Booth number: 1501-9

View all German exhibitors and products

News & Innovations

Our CI-SCREEN Technology has been published in Nature Communications ..
Use functionally immortalized cell systems as an alternative to freshly isolated primary cells. CI-SCREEN cell lines from various tissue and species can be applied for drug screening, characterization and personalized medicine. | Further reading

Start of clinical trial with TCR immunotherapy MDG1011
Target: PRAME (Preferentially Expressed Antigen in Melanoma) is a well characterized tumor antigen overexpressed in multiple hematological and solid tumor indications The drug, MDG1011: T cells expressing a HLA-A*02:01-restricted T cell receptor (TCR) specific for PRAME Trial outline: 1) Combi... | Further reading

Genekam DNA-Test for detection of yellow fever virus (a new threat to the world)
Genekam Biotechnology AG, Germany has developed a new DNA kit for detection of yellow fever virus. This kit is with CE-IVD and can be used in diagnostic in Europe and other CE accepting countries. At present, there are outbreaks of yellow fever in Africa and WHO is keeping a close eye on situati... | Further reading

News & Innovations
Your personal organizer

Your personal organizer

Print list
This is your personal organizer to manage your contacts to the German exhibitors.